JS, F., & Freeman, J. S. (2010). A physiologic and pharmacological basis for implementation of incretin hormones in the treatment of type 2 diabetes mellitus. Mayo Clinic Proceedings, 85, S5. https://doi.org/10.4065/mcp.2010.0467
Chicago Style (17th ed.) CitationJS, Freeman, and Jeffrey S. Freeman. "A Physiologic and Pharmacological Basis for Implementation of Incretin Hormones in the Treatment of Type 2 Diabetes Mellitus." Mayo Clinic Proceedings 85 (2010): S5. https://doi.org/10.4065/mcp.2010.0467.
MLA (9th ed.) CitationJS, Freeman, and Jeffrey S. Freeman. "A Physiologic and Pharmacological Basis for Implementation of Incretin Hormones in the Treatment of Type 2 Diabetes Mellitus." Mayo Clinic Proceedings, vol. 85, 2010, p. S5, https://doi.org/10.4065/mcp.2010.0467.